Daniel L. Raines
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Daniel L. Raines has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Douglas G. Adler
University of Utah School of Medicine, 30 North 1900 East 4R118, Salt Lake City, UT 84132, USA
1 shared publicationFred A. Lopez
Louisiana State University Health Sciences Center
1 shared publication- John D. England
Department of Neurology, Louisiana State University Health Sciences Center, School of Medicine, 1542 Tulane Avenue, New Orleans, LA 70112, United States
1 shared publication - Rima El-Abassi
Louisiana State University Health Sciences Center
1 shared publication
Latest Publications
- 1 April 2021
- Published by Elsevier in Gastrointestinal Endoscopy Clinics of North America
- Vol. 31 (2) , 317-330
The Role of Provocative Testing and Localization of the Video Capsule Endoscope in the Management of Small Intestinal Bleeding
- 1 April 2021
- Published by Elsevier in Gastrointestinal Endoscopy Clinics of North America
- Vol. 31 (2) , 317-330
The Role of Provocative Testing and Localization of the Video Capsule Endoscope in the Management of Small Intestinal Bleeding
- 4 May 2011
- Published by Springer Nature in Current Gastroenterology Reports
- Vol. 13 (4) , 344-350
Clostridium Difficile Infection in Non–HIV-Immunocompromised Patients and in HIV-Infected Patients
Clostridium difficile infection is a common cause of morbidity in patients with HIV infection and in patients with non-HIV immune deficiency. The frequency of C. difficile–associated diarrhea (CDAD) seen in these two patient populations has been attributed to immune deficiency, as well as to increased exposure to hospital environments and antibiotic therapy, both of which are major risk factors for CDAD. This article reviews recent data useful in the evaluation, treatment, and prevention of C. difficile infection in these patient groups. Recent publications relating to C. difficile infection in specific immunocompromised conditions are also discussed.
- 4 May 2011
- Published by Springer Nature in Current Gastroenterology Reports
- Vol. 13 (4) , 344-350
Clostridium Difficile Infection in Non–HIV-Immunocompromised Patients and in HIV-Infected Patients
Clostridium difficile infection is a common cause of morbidity in patients with HIV infection and in patients with non-HIV immune deficiency. The frequency of C. difficile–associated diarrhea (CDAD) seen in these two patient populations has been attributed to immune deficiency, as well as to increased exposure to hospital environments and antibiotic therapy, both of which are major risk factors for CDAD. This article reviews recent data useful in the evaluation, treatment, and prevention of C. difficile infection in these patient groups. Recent publications relating to C. difficile infection in specific immunocompromised conditions are also discussed.